(ADVANCING CURATIVE TREATMENTS)
Saturday, March 25 - Sunday, March 26, 2023
HBV/HDV-ACT will provide attendees with an opportunity to learn from leading researchers about the latest innovative science on HBV/HDV and engage in interactive discussions. The primary objective of the conference is to meet the educational needs of research and development stakeholders and healthcare professionals who seek to improve the lives of patients with HBV and HDV. This conference will be offered live and virtually for attendees to participate in from around the world.